Q32 Bio (QTTB) Invested Capital (2017 - 2025)
Historic Invested Capital for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to -$12.2 million.
- Q32 Bio's Invested Capital fell 16160.98% to -$12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 16160.98%. This contributed to the annual value of $8.8 million for FY2024, which is 10481.86% up from last year.
- According to the latest figures from Q3 2025, Q32 Bio's Invested Capital is -$12.2 million, which was down 16160.98% from -$6.0 million recorded in Q2 2025.
- Q32 Bio's 5-year Invested Capital high stood at $266.3 million for Q1 2022, and its period low was -$182.0 million during Q4 2023.
- Over the past 5 years, Q32 Bio's median Invested Capital value was $33.5 million (recorded in 2024), while the average stood at $61.3 million.
- As far as peak fluctuations go, Q32 Bio's Invested Capital plummeted by 20228.4% in 2023, and later soared by 13778.59% in 2024.
- Q32 Bio's Invested Capital (Quarter) stood at $169.7 million in 2021, then rose by 4.91% to $178.0 million in 2022, then tumbled by 202.28% to -$182.0 million in 2023, then skyrocketed by 104.82% to $8.8 million in 2024, then tumbled by 239.26% to -$12.2 million in 2025.
- Its Invested Capital was -$12.2 million in Q3 2025, compared to -$6.0 million in Q2 2025 and $648000.0 in Q1 2025.